Zinzino group revenue increased with a total of 26 % in Q1 compared with the previous year.

 

The revenue in March for Zinzino's sales markets increased by 29% and amounted to SEK 342.2 (265.8) million. Faun Pharma's external sales decreased and amounted to SEK 6.6 (7.1) million. Overall, the Group increased revenues by 28% to SEK 348.8 (272.9) million compared with the previous year.

The group revenue increased with 26 % for Q1 2026 compared with the first quarter last year and amounted to SEK 915.4 (723.7) million.

Revenues were distributed as follows:

Regions, mSEK	26-mar	25-mar	Change	Q1 2026	Q1 2025	Change
The Nordics	27.1	26.6	2%	77.7	77.1	1%
Central Europe	103.3	69.6	48%	274.9	196.4	40%
East Europe	29.5	34.0	-13%	85.1	97.2	-12%
South & West Europe	59.2	42.9	38%	155.7	124.9	25%
The Baltics	10.3	9.4	10%	29.2	28.7	2%
North America	80.2	56.1	43%	188.7	110.3	71%
South America	4.3	0.6	617%	11.8	2.3	413%
Asia-Pacific	25.9	24.6	5%	66.8	65.8	2%
Africa	2.4	2.0	20%	6.5	5.0	30%
Zinzino	342.2	265.8	29%	896.4	707.7	27%
Faun Pharma	6.6	7.1	-7%	19.0	16.0	19%
Zinzino Group	348.8	272.9	28%	915.4	723.7	26%

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Island.

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA, Mexico

-South America: Peru, Colombia

-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand

-Africa: South Africa

 

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com

 

Pictures for publication free of charge: marketing@zinzino.com